[1]
|
Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., Russo, E. and Amedei, A. (2019) Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. International Journal of Molecular Sciences, 20, 395.
https://doi.org/10.3390/ijms20020395
|
[2]
|
Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K. and Knight, R. (2012) Diversity, Stability and Resilience of the Human Gut Microbiota. Nature, 489, 220-230. https://doi.org/10.1038/nature11550
|
[3]
|
Tremaroli, V. and Bäckhed, F. (2012) Functional Interactions between the Gut Microbiota and Host Metabolism. Nature, 489, 242-249. https://doi.org/10.1038/nature11552
|
[4]
|
Albillos, A., de Gottardi, A. and Rescigno, M. (2020) The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy. Journal of Hepatology, 72, 558-577. https://doi.org/10.1016/j.jhep.2019.10.003
|
[5]
|
Cassard, A.M. and Ciocan, D. (2017) Microbiota, a Key Player in Alcoholic Liver Disease. Clinical and Molecular Hepatology, 24, 100-107. https://doi.org/10.3350/cmh.2017.0067
|
[6]
|
Hartmann, P., Seebauer, C.T. and Schnabl, B. (2015) Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk. Alcoholism: Clinical and Experimental Research, 39, 763-775. https://doi.org/10.1111/acer.12704
|
[7]
|
Szabo, G. (2014) Gut-Liver Axis in Alcoholic Liver Disease. Gastroenterology, 148, 30-36.
https://doi.org/10.1053/j.gastro.2014.10.042
|
[8]
|
Xie, G., Zhong, W., Zheng, X., Li, Q., Qiu, Y., Li, H., Chen, H., Zhou, Z. and Jia, W. (2013) Chronic Ethanol Consumption Alters Mammalian Gastrointestinal Content Metabolites. Journal of Proteome Research, 12, 3297-3306.
https://doi.org/10.1021/pr400362z
|
[9]
|
Macnaughtan, J. and Jalan, R. (2015) Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis. The American Journal of Gastroenterology, 110, 1399-1410. https://doi.org/10.1021/pr400362z
|
[10]
|
Leclercq, S., Matamoros, S., Cani, P.D., et al. (2014) Intestinal Permeability, Gut-Bacterial Dysbiosis, and Behavioral Markers of Alcohol-Dependence Severity. Proceedings of the National Academy of Sciences of the United States of America, 111, E4485-E4493. https://doi.org/10.1073/pnas.1415174111
|
[11]
|
Pradere, J.P., Troeger, J.S., Dapito, D.H., Mencin, A.A. and Schwabe, R.F. (2010) Toll-Like Receptor 4 and Hepatic Fibrogenesis. Seminars in Liver Disease, 30, 232-244. https://doi.org/10.1055/s-0030-1255353
|
[12]
|
Chen, P., et al. (2015) Supplementation of Saturated Long-Chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-Induced Liver Injury in Mice. Gastroenterology, 148, 203-214.e216.
https://doi.org/10.1053/j.gastro.2014.09.014
|
[13]
|
Llopis, M., Cassard, A.M., Wrzosek, L., et al. (2016) Intestinal Microbiota Contributes to Individual Susceptibility to Alcoholic Liver Disease. Gut, 65, 830-839. https://doi.org/10.1136/gutjnl-2015-310585
|
[14]
|
Younossi, Z.M., Marchesini, G., Pinto-Cortez, H. and Petta, S. (2018) Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Transplantation, 2018, Article ID: 30335697. https://doi.org/10.1002/lt.25003
|
[15]
|
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版) [J]. 胃肠病学和肝病学杂志, 2010, 19(6): 483-487.
|
[16]
|
非酒精性脂肪性肝病防治指南(2018更新版) [J]. 传染病信息, 2018, 31(5): 393-402+420.
|
[17]
|
Michelotti, G.A., Machado, M.V. and Diehl, A.M. (2013) NAFLD, NASH and Liver Cancer. Nature Reviews Gastroenterology Hepatology, 10, 656-665. https://doi.org/10.1038/nrgastro.2013.183
|
[18]
|
Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism, 65, 1038-1048. https://doi.org/10.1016/j.metabol.2015.12.012
|
[19]
|
柳惠未, 叶桦. 肠道菌群在非酒精性脂肪性肝病发病机制中的作用[J]. 中国现代医生, 2019, 57(6): 163-168.
|
[20]
|
廉晓晓, 郭晓霞. 肠-肝轴学说的研究进展[J]. 中西医结合肝病杂志, 2017, 27(4): 251-254.
|
[21]
|
Le Roy, T., Llopis, M., Lepage, P., et al. (2013) Intestinal Microbiota Determines Development of Non-Alcoholic Fatty Liver Disease in Mice. Gut, 62, 1787-1794. https://doi.org/10.1136/gutjnl-2012-303816
|
[22]
|
World Health Organization (2017) Global Hepatitis Report 2017. Geneva.
https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en
|
[23]
|
World Health Organization (2016) Global Health Sector Strategy on Viral Hepatitis, 2016-2021. Geneva.
http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua51
|
[24]
|
Aly, A.M., Adel, A., El-Gendy, A.O., Essam, T.M. and Aziz, R.K. (2016) Gut Microbiome Alterations in Patients with Stage 4 Hepatitis C. Gut Pathogens, 8, 42. https://doi.org/10.1186/s13099-016-0124-2
|
[25]
|
Heidrich, B., Vital, M., Plumeier, I., et al. (2018) Intestinal Microbiota in Patients with Chronic Hepatitis C with and without Cirrhosis Compared with Healthy Controls. Liver International, 38, 50-58. https://doi.org/10.1111/liv.13485
|
[26]
|
Inoue, T., Nakayama, J., Moriya, K., Kawaratani, H., Momoda, R., Ito, K., Iio, E., Nojiri, S., Fujiwara, K., Yoneda, M., Yoshiji, H. and Tanaka, Y. (2018) Gut Dysbiosis Associated with Hepatitis C Virus Infection. Clinical Infectious Diseases, 67, 869-877. https://doi.org/10.1093/cid/ciy205
|
[27]
|
王睿, 王绮夏, 马雄. 肠道微生态与自身免疫性肝病[J]. 实用肝脏病杂志, 2020, 23(6): 773-776.
|
[28]
|
Abe, K., Fujita, M., Hayashi, M., Okai, K., Takahashi, A. and Ohira, H. (2020) Gut and Oral Microbiota in Autoimmune Liver Disease. Fukushima Journal of Medical Science, 65, 71-75. https://doi.org/10.5387/fms.2019-21
|
[29]
|
Lin, R., Zhou, L., Zhang, J. and Wang, B. (2015) Abnormal Intestinal Permeability and Microbiota in Patients with Autoimmune Hepatitis. International Journal of Clinical and Experimental Pathology, 8, 5153-5160.
|
[30]
|
Wei, Y., Li, Y., Yan, L., Sun, C., Miao, Q., Wang, Q., Xiao, X., Lian, M., Li, B., Chen, Y., Zhang, J., Li, Y., Huang, B., Li, Y., Cao, Q., Fan, Z., Chen, X., Fang, J.Y., Gershwin, M.E., Tang, R. and Ma, X. (2019) Alterations of Gut Microbiome in Autoimmune Hepatitis. Gut, 69, 569-577. https://doi.org/10.1136/gutjnl-2018-317836
|
[31]
|
Abe, K., Takahashi, A., Fujita, M., Imaizumi, H., Hayashi, M., Okai, K., et al. (2018) Dysbiosis of Oral Microbiota and Its Association with Salivary Immunological Biomarkers in Autoimmune Liver Disease. PLoS ONE, 13, e0198757.
https://doi.org/10.1371/journal.pone.0198757
|
[32]
|
Kaplan, M.M. and Gershwin, M.E. (2005) Primary Biliary Cirrhosis. The New England Journal of Medicine, 353, 1261-1273. https://doi.org/10.1056/NEJMra043898
|
[33]
|
Selmi, C., Bowlus, C.L., Gershwin, M.E. and Coppel, R.L. (2011) Primary Biliary Cirrhosis. The Lancet, 377, 1600-1609.
https://doi.org/10.1016/S0140-6736(10)61965-4
|
[34]
|
Yu, L.X. and Schwabe, R.F. (2017) The Gut Microbiome and Liver Cancer: Mechanisms and Clinical Translation. Nature Reviews Gastroenterology & Hepatology, 14, 527-539. https://doi.org/10.1038/nrgastro.2017.72
|
[35]
|
Gupta, H., Youn, G.S., Shin, M.J. and Suk, K.T. (2019) Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms, 7, 121. https://doi.org/10.20944/preprints201903.0267.v1
|
[36]
|
Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., Xie, H., Chen, X., Shao, L., Zhang, R., Xu, S., Zhang, H., Cui, G., Chen, X., Sun, R., Wen, H., Lerut, J.P., Kan, Q., Li, L. and Zheng, S. (2019) Gut Microbiome Analysis as a Tool towards Targeted Non-Invasive Biomarkers for Early Hepatocellular Carcinoma. Gut, 68, 1014-1023.
https://doi.org/10.1136/gutjnl-2017-315084
|
[37]
|
Wan, M.L.Y. and El-Nezami, H. (2018) Targeting Gut Microbiota in Hepatocellular Carcinoma: Probiotics as a Novel Therapy. Hepatobiliary Surgery, 7, 11-20. https://doi.org/10.21037/hbsn.2017.12.07
|
[38]
|
Grat, M., Wronka, K.M., Krasnodebski, M., Masior, L., Lewandowski, Z., Kosinska, I., Grat, K., Stypulkowski, J., Rejowski, S., Wasilewicz, M., Galecka, M., Szachta, P. and Krawczyk, M. (2016) Profile of Gut Microbiota Associated with the Presence of Hepatocellular Cancer in Patients with Liver Cirrhosis. Transplantation Proceedings, 48, 1687-1691. https://doi.org/10.1016/j.transproceed.2016.01.077
|
[39]
|
Louis, P. and Flint, H.J. (2009) Diversity, Metabolism and Microbial Ecology of Butyrate-Producing Bacteria from the Human Large Intestine. FEMS Microbiology Letters, 294, 1-8. https://doi.org/10.1111/j.1574-6968.2009.01514.x
|